IP Library Granted Patent US 10,420,939
Granted Patent B2
US 10,420,939 · App. 15/454,041 · Granted Sep 24, 2019

Nerve stimulation to promote neuroregeneration

Inventors: Bradley C. Gill (Cleveland, OH); Yaw A. Nyame (Cleveland, OH); Eric A. Klein (Cleveland, OH)
Assignee: THE CLEVELAND CLINIC FOUNDATION
A61N1/36103A61N1/0502A61N1/0551A61N1/36017A61N1/36107A61N1/36164
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,420,939
App. No.
15/454,041
Granted
Sep 24, 2019
Kind
B2
Abstract

Temporary or sub-threshold electrical stimulation to promote recovery of a damaged or injured nerve. Methods include promoting neuroregeneration of a nerve iatrogenically injured during a medical procedure performed on a target site of a patient's body. Methods include placing an electrical lead in electrical communication with the injured or damaged nerve. Methods further include temporarily stimulating the nerve and/or applying sub-threshold stimulation to the nerve to promote neuroregeneration of the nerve. The nerve can be a peripheral nerve.

Claims (20)

1. A method of promoting neuroregeneration of a damaged or injured nerve in a human's body comprising:

placing an electrical lead in electrical communication with the nerve; and

delivering an electrical signal to the nerve for a period of time between at least a portion of one day to six weeks to promote neuroregeneration of the nerve wherein delivering an electrical signal to the nerve comprises delivering a sub-threshold electrical signal to the nerve, wherein the sub-threshold electrical signal promotes neuroregeneration of the nerve but does not stimulate the nerve to a level that triggers the nerve's physiological effect, wherein the electrical signal has an amplitude of between about 10 to 40 mA, a frequency between about 10-60 Hz, and a pulse width of between about 0.22-2.0 ms.

2. The method of claim 1 , wherein the electrical signal is charge-balanced.

3. The method of claim 1 , wherein the electrical signal is delivered for a plurality of days, and the plurality of days are non-consecutive.

4. The method of claim 1 , wherein the nerve is iatrogenically damaged or injured during a medical procedure performed on a target site of a patient's body.

5. The method of claim 4 , wherein the medical procedure involves surgical dissection or visualization of the nerve.

6. The method of claim 4 , wherein the medical procedure is a prostatectomy, the target site is the prostate, and the nerve is a cavernous nerve.

7. The method of claim 4 , wherein the medical procedure is a thyroidectomy, the target site is a thyroid gland, and the nerve is a laryngeal nerve.

8. The method of claim 4 , wherein the medical procedure is a parotidectomy, the target site is a parotid gland, and the nerve is a facial nerve.

9. The method of claim 4 , wherein the medical procedure is extremity surgery, the target site is an extremity of the patient's body, and the nerve is a peripheral nerve.

10. The method of claim 4 , wherein the medical procedure is childbirth, the target site is the birth canal, and the nerve is a pudendal nerve.

11. The method of claim 4 , wherein promoting neuroregeneration comprises improving a complication associated with the medical procedure.

12. The method of claim 11 , wherein the complication is erectile dysfunction.

13. The method of claim 1 , wherein the nerve is iatrogenically damaged or injured during a medical procedure performed on a target site of a patient's body and delivering an electrical signal comprises delivering the electrical signal to the nerve after the iatrogenic injury or damage.

14. The method of claim 1 , wherein the nerve is iatrogenically damaged or injured during a medical procedure performed on a target site of a patient's body and placing the electrical lead comprises placing the electrical lead in electrical communication with the nerve before the medical procedure is performed.

15. The method of claim 1 , wherein the nerve is iatrogenically damaged or injured during a medical procedure performed on a target site of a patient's body and placing the electrical lead comprises placing the electrical lead in electrical communication with the nerve while the medical procedure is performed.

16. The method of claim 1 , wherein the electrode is a wire electrode.

17. The method of claim 1 , further comprising chemically stimulating the nerve.

18. The method of claim 1 , wherein the lead is percutaneously placed in direct electrical contact with the nerve.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2017
From: GILL, BRADLEY C.; NYAME, YAW A.; KLEIN, ERIC A.
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 043918/0311 →
Continuity (2)
Provisional Application 62316465 · Mar 31, 2016
Related Publication 20170281945A1 · Oct 5, 2017